arrow
P

Paul Harmatz

University of North Carolina School of Medicine
H指数:65
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intrathecal idursulfase-IT in children younger than 3 years with neuronopathic mucopolysaccharidosis II in a single-arm, open-label, phase 2/3 substudy and extension

鞘内注射依度硫酸酶-IT治疗3岁以下神经元性黏多糖贮积症II型的单臂、开放标签、II/III期子研究和扩展研究

2026-02-220
OAAI
Clinical characteristics and real-world outcomes in patients with mucopolysaccharidosis II over 18 years: final report of the hunter outcome survey

黏多糖贮积症II型患者18年临床特征与真实世界结局:Hunter结局调查最终报告

2025-11-020
PRE
Long-term efficacy and safety of arimoclomol in Niemann-Pick disease type C: Final results of the phase 2/3 NPC-002 48-month open-label extension trial

Arimoclomol在尼曼-皮克病C型中的长期疗效与安全性:NPC-002 48个月开放标签扩展试验2/3期的最终结果

2025-07-070
PRE
Persistent growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health-related quality of life
2024-12-010
OAAI